A non-canonical pathway regulates ER stress signaling and blocks ER stress-induced apoptosis and heart failure

作者：Yao, Yufeng; Lu, Qiulun; Hu, Zhenkun; Yu, Yubin; Chen, Qiuyun; Wang, Qing K.^*

来源：Nature Communications, 2017, 8(1): 133.

DOI：10.1038/s41467-017-00171-w

• ENDOPLASMIC-RETICULUM STRESS
• UNFOLDED PROTEIN RESPONSE
• KLIPPEL-TRENAUNAY-SYNDROME
• CELL-DEATH
• NEURODEGENERATIVE DISEASES
• CARDIOVASCULAR-DISEASE
• CARDIAC-HYPERTROPHY
• QUALITY-CONTROL
• AGGF1
• GENE

Endoplasmic reticulum stress is an evolutionarily conserved cell stress response associated with numerous diseases, including cardiac hypertrophy and heart failure. The major endoplasmic reticulum stress signaling pathway causing cardiac hypertrophy involves endoplasmic reticulum stress sensor PERK (protein kinase-like kinase) and eIF2 alpha-ATF4-CHOP signaling. Here, we describe a non-canonical, AGGF1-mediated regulatory system for endoplasmic reticulum stress signaling associated with increased p-eIF2 alpha and ATF4 and decreased sXBP1 and CHOP. Specifically, we see a reduced AGGF1 level consistently associated with induction of endoplasmic reticulum stress signaling in mouse models and human patients with heart failure. Mechanistically, AGGF1 regulates endoplasmic reticulum stress signaling by inhibiting ERK1/2 activation, which reduces the level of transcriptional repressor ZEB1, leading to induced expression of miR-183-5p. miR-183-5p post-transcriptionally downregulates CHOP and inhibits endoplasmic reticulum stress-induced apoptosis. AGGF1 protein therapy and miR-183-5p regulate endoplasmic reticulum stress signaling and block endoplasmic reticulum stress-induced apoptosis, cardiac hypertrophy, and heart failure, providing an attractive paradigm for treatment of cardiac hypertrophy and heart failure.

• 出版日期2017-7-25
• 单位华中科技大学